Skip to main content
SpringerLink
Log in

Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy

  • CE - Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Darshan D, Anderson GJ (2009) Interacting signals in the control hepcidin expression. Biometals 22:77–87

    Article  CAS  PubMed  Google Scholar 

  2. Adamsky K, Weizer O, Amariglio N et al (2004) Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 124:123–124

    Article  CAS  PubMed  Google Scholar 

  3. Porter JB, Abeysinghe RD, Marshall L et al (1996) Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 88:705–713

    CAS  PubMed  Google Scholar 

  4. Biasiotto G, Roetto A, Daraio F et al (2004) Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis 33:338–343

    Article  CAS  PubMed  Google Scholar 

  5. De Diego C, Opazo S, Murga MJ et al (2006) H63D homozygotes with hyperferritinaemia: is this genotype, the primary cause of iron overload? Eur J Haematol 78:66–71

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors declare that they have no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Maggiore Policlinico, Mangiagalli and Regina Elena Foundation IRCCS, University of Milan, Milan, Italy

    Lorena Duca, Paola Delbini, Isabella Nava & Maria Domenica Cappellini

  2. Department of Pediatrics “G.Martino” Policlinico, Faculty of Medicine, University of Messina, Via Consolare Valeria, Messina, Italy

    Anna Meo

Authors
  1. Lorena Duca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Delbini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isabella Nava
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Domenica Cappellini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna Meo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Meo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duca, L., Delbini, P., Nava, I. et al. Hepcidin mutation in a β-thalassemia major patient with persistent severe iron overload despite chelation therapy. Intern Emerg Med 5, 83–85 (2010). https://doi.org/10.1007/s11739-009-0306-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-009-0306-8

Keywords

Search

Navigation